Pitasor 2

Pitasor 2

pitavastatin

Manufacturer:

Unison

Distributor:

Medline

Marketer:

Medline
Concise Prescribing Info
Contents
Pitavastatin
Indications/Uses
Hyperlipidaemias, mixed dyslipidaemia.
Dosage/Direction for Use
Adult Hyperlipidaemia & mixed dyslipidaemia 1-4 mg once daily. In combination w/ erythromycin & rifampicin: Max: 1- or 2 mg, respectively.
Administration
May be taken with or without food.
Contraindications
Active liver disease including unexplained, persistent elevations in serum aminotransferase (transaminase) conc. Concomitant use w/ ciclosporin. Pregnancy & lactation.
Special Precautions
Patients w/ predisposing factors for myopathy; alcoholism. Renal impairment.
Adverse Reactions
Liver enzyme abnormalities, myalgia, muscle spasm, back pain, diarrhoea, constipation, pain in extremities, arthralgia, headache, dizziness, influenza, nasopharyngitis, abdominal discomfort, abdominal pain, dyspepsia, nausea, asthenia, malaise, fatigue, hepatitis, jaundice, hypoaesthesia, insomnia, depression, interstitial lung disease, erectile dysfunction, cognitive impairment (eg, memory loss & impairment, confusion, forgetfulness, amnesia). Myopathy & rhabdomyolysis w/ acute renal failure secondary to myoglobinuria; hepatic failure.
Drug Interactions
Increased bioavailability w/ erythromycin & rifampicin. Increased risk of myopathy/rhabdomyolysis w/ gemfibrozil, colchicine, niacin & other fibrates. Significant increase in exposure w/ ciclosporin.
ATC Classification
C10AA08 - pitavastatin ; Belongs to the class of HMG CoA reductase inhibitors. Used in the treatment of hyperlipidemia.
Presentation/Packing
Form
Pitasor 2 tab 2 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in